The role of CD44 in epithelial–mesenchymal transition and cancer development

References

• SpringFADalchauRDanielsGLThe Ina and Inb blood group antigens are located on a glycoprotein of 80,000 MW (the CDw44 glycoprotein) whose expression is influenced by the In(Lu) geneImmunology198864137432454887
   PubMed Web of Science ®Google Scholar
• RodrigoJPDominguezFAlvarezCGonzalezMVHerreroASuarezCClinicopathologic significance of expression of CD44s and CD44v6 isoforms in squamous cell carcinoma of the supraglottic larynxAm J Clin Pathol20021181677212109858
   PubMed Web of Science ®Google Scholar
• ErbUMegaptcheAPGuXBuchlerMWZollerMCD44 standard and CD44v10 isoform expression on leukemia cells distinctly influences niche embedding of hematopoietic stem cellsJ Hematol Oncol201472924684724
   PubMed Web of Science ®Google Scholar
• MisraSHascallVCMarkwaldRRGhatakSInteractions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancerFront Immunol2015620125999946
   PubMed Web of Science ®Google Scholar
• MisraSHeldinPHascallVCHyaluronan-CD44 interactions as potential targets for cancer therapyFEBS J201127891429144321362138
   PubMed Web of Science ®Google Scholar
• PontaHShermanLHerrlichPACD44: from adhesion molecules to signalling regulatorsNat Rev Mol Cell Biol200341334512511867
   PubMed Web of Science ®Google Scholar
• TurleyEANoblePWBourguignonLYSignaling properties of hyaluronan receptorsJ Biol Chem200227774589459211717317
   PubMed Web of Science ®Google Scholar
• MisraSHascallVCDe GiovanniCMarkwaldRRGhatakSDelivery of CD44shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICEJ Biol Chem200928418124321244619246453
   PubMed Web of Science ®Google Scholar
• van der WindtGJSchoutenMZeerlederSFlorquinSvan der PollTCD44 is protective during hyperoxia-induced lung injuryAm J Respir Cell Mol Biol201144337738320463290
   PubMed Web of Science ®Google Scholar
• ChanmeeTOntongPKimataKItanoNKey roles of hyaluronan and its CD44 receptor in the stemness and survival of cancer stem cellsFront Oncol2015518026322272
   PubMed Web of Science ®Google Scholar
• NaorDSionovRVIsh-ShalomDCD44: structure, function, and association with the malignant processAdv Cancer Res1997712413199111868
   PubMed Web of Science ®Google Scholar
• JangBILiYGrahamDYCenPThe role of CD44 in the pathogenesis, diagnosis, and therapy of gastric cancerGut Liver20115439740522195236
   PubMed Web of Science ®Google Scholar
• NaganoOSayaHMechanism and biological significance of CD44 cleavageCancer Sci2004951293093515596040
   PubMed Web of Science ®Google Scholar
• KwongLNDoveWFAPC and its modifiers in colon cancerAdv Exp Med Biol20096568510619928355
   PubMed Web of Science ®Google Scholar
• WuKNingZZengJSilibinin inhibits beta-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemnessCell Signal201325122625263324012496
   PubMed Web of Science ®Google Scholar
• UchinoMKojimaHWadaKNuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cellsBMC Cancer20101041420696077
   PubMed Web of Science ®Google Scholar
• YuGYaoWXiaoWLiHXuHLangBMicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44J Exp Clin Cancer Res20143377925551284
   PubMed Web of Science ®Google Scholar
• XieGYaoQLiuYIL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere culturesInt J Oncol20124041171117922134360
   PubMed Web of Science ®Google Scholar
• RossJSSheehanCEWilliamsSSMalfetanoJHSzyfelbeinWMKallakuryBVDecreased CD44 standard form expression correlates with prognostic variables in ovarian carcinomasAm J Clin Pathol2001116112212811447742
   PubMed Web of Science ®Google Scholar
• LeungELFiscusRRTungJWNon-small cell lung cancer cells expressing CD44 are enriched for stem cell-like propertiesPLoS One2010511e1406221124918
   PubMed Web of Science ®Google Scholar
• BrownRLReinkeLMDamerowMSCD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progressionJ Clin Invest201112131064107421393860
   PubMed Web of Science ®Google Scholar
• ShangZCaiQZhangMA switch from CD44(+) cell to EMT cell drives the metastasis of prostate cancerOncotarget2015621202121625483103
   PubMedGoogle Scholar
• XuGFZhangWJSunQXuXZouXGuanWCombined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancerWorld J Surg Oncol20141236825441488
   PubMed Web of Science ®Google Scholar
• SuYJLaiHMChangYWChenGYLeeJLDirect reprogramming of stem cell properties in colon cancer cells by CD44EMBO J201130153186319921701559
   PubMed Web of Science ®Google Scholar
• MahabirRTaninoMElmansuriASustained elevation of Snail promotes glialmesenchymal transition after irradiation in malignant gliomaNeuro Oncol201416567168524357458
   PubMed Web of Science ®Google Scholar
• ChungSSArohCVadgamaJVConstitutive activation of STAT3 signaling regulates hTERT and promotes stem cell-like traits in human breast cancer cellsPLoS One2013812e8397124386318
   PubMed Web of Science ®Google Scholar
• KinugasaHWhelanKATanakaKMitochondrial SOD2 regulates epithelial-mesenchymal transition and cell populations defined by differential CD44 expressionOncogene201534415229523925659582
   PubMed Web of Science ®Google Scholar
• FernandoJMalfettoneACepedaEBA mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cellsInt J Cancer20151364E161E17225053293
   PubMed Web of Science ®Google Scholar
• SongYLiJZhuYMicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinomaOncotarget2014522116691168025375090
   PubMedGoogle Scholar
• TianLLiMGeJMiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumoursTumour Biol20143565953596324682952
   PubMedGoogle Scholar
• WangPCWengCCHouYSActivation of VCAM-1 and its associated molecule CD44 leads to increased malignant potential of breast cancer cellsInt J Mol Sci20141533560357924583847
   PubMed Web of Science ®Google Scholar
• XingPLiJGJinFFascin, an actin-bundling protein, promotes breast cancer progression in vitroCell Biochem Funct201129430331021491467
   PubMed Web of Science ®Google Scholar
• LiLLiuCAmatoRJChangJTDuGLiWCDKL2 promotes epithelial-mesenchymal transition and breast cancer progressionOncotarget2014521108401085325333262
   PubMedGoogle Scholar
• LiJZhouBPActivation of beta-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like charactersBMC Cancer2011114921284870
   PubMed Web of Science ®Google Scholar
• YuMSmolenGAZhangJA developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progressionGenes Dev200923151737174219651985
   PubMed Web of Science ®Google Scholar
• ManiSAGuoWLiaoMJThe epithelial-mesenchymal transition generates cells with properties of stem cellsCell2008133470471518485877
   PubMed Web of Science ®Google Scholar
• FangXCaiYLiuJTwist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewalOncogene201130474707472021602879
   PubMed Web of Science ®Google Scholar
• LeeJKJooKMLeeJYoonYNamDHTargeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signalingOnco Targets Ther201471933194425364264
   PubMed Web of Science ®Google Scholar
• ZhangZFilhoMSNorJEThe biology of head and neck cancer stem cellsOral Oncol20124811922070916
   PubMed Web of Science ®Google Scholar
• WayTDHuangJTChouCHHuangCHYangMHHoCTEmodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the beta-catenin and Akt pathwaysEur J Cancer201450236637824157255
   PubMed Web of Science ®Google Scholar
• MasuiTOtaIYookJISnail-induced epithelial-mesenchymal transition promotes cancer stem cell-like phenotype in head and neck cancer cellsInt J Oncol201444369369924365974
   PubMed Web of Science ®Google Scholar
• DeepGJainAKRamtekeASNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherinMol Cancer2014133724565133
   PubMed Web of Science ®Google Scholar
• Marin-AguileraMCodony-ServatJReigOEpithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancerMol Cancer Ther20141351270128424659820
   PubMed Web of Science ®Google Scholar
• Bhat-NakshatriPAppaiahHBallasCSLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24− phenotypeBMC Cancer20101041120691079
   PubMed Web of Science ®Google Scholar
• JuSYChiouSHSuYMaintenance of the stemness in CD44(+) HCT-15 and HCT-116 human colon cancer cells requires miR-203 suppressionStem Cell Res20141218610024145190
   PubMed Web of Science ®Google Scholar
• ChoSHParkYSKimHJCD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasionInt J Oncol201241121121822552741
   PubMed Web of Science ®Google Scholar
• YuDShinHSLeeYSLeeYCmiR-106b modulates cancer stem cell characteristics through TGF-beta/Smad signaling in CD44-positive gastric cancer cellsLab Invest201494121370138125286029
   PubMed Web of Science ®Google Scholar
• WangLYangHAbelEVATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesisGenes Dev201529217118325593307
   PubMed Web of Science ®Google Scholar
• WangDZhuHLiuYThe low chamber pancreatic cancer cells had stem-like characteristics in modified transwell system: is it a novel method to identify and enrich cancer stem-like cells?Biomed Res Int2014201476030324689055
   PubMed Web of Science ®Google Scholar
• JiangWZhangYKaneKTCD44 regulates pancreatic cancer invasion through MT1-MMPMol Cancer Res201513191525566991
   PubMed Web of Science ®Google Scholar
• NevoIWoolardKCamMIdentification of molecular pathways facilitating glioma cell invasion in situPLoS One2014911e11178325365423
   PubMed Web of Science ®Google Scholar
• MimaKHayashiHImaiKHigh CD44s expression is associated with the EMT expression profile and intrahepatic dissemination of hepatocellular carcinoma after local ablation therapyJ Hepatobiliary Pancreat Sci201320442943423238743
   PubMed Web of Science ®Google Scholar
• ReinkeLMXuYChengCSnail represses the splicing regulator epithelial splicing regulatory protein 1 to promote epithelial-mesenchymal transitionJ Biol Chem201228743364353644222961986
   PubMed Web of Science ®Google Scholar
• SaitoSOkabeHWatanabeMCD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancerOncol Rep20132941570157823404221
   PubMed Web of Science ®Google Scholar
• GengSGuoYWangQLiLWangJCancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinomaArch Dermatol Res20133051354722740085
   PubMed Web of Science ®Google Scholar
• ZhangYWeiJWangHEpithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancerOncol Rep20122751599160522322379
   PubMed Web of Science ®Google Scholar
• LiuSCongYWangDBreast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterpartsStem Cell Rep2013217891
   Web of Science ®Google Scholar
• LeontovichAAZhangSQuatraroCRaf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cellsInt J Oncol20124061858186422447278
   PubMed Web of Science ®Google Scholar
• ArifKHussainIReaCEl-SheemyMThe role of Nanog expression in tamoxifen-resistant breast cancer cellsOnco Targets Ther201581327123426082649
   PubMed Web of Science ®Google Scholar
• DalerbaPDyllaSJParkIKPhenotypic characterization of human colorectal cancer stem cellsProc Natl Acad Sci U S A200710424101581016317548814
   PubMed Web of Science ®Google Scholar
• DuLWangHHeLCD44 is of functional importance for colorectal cancer stem cellsClin Cancer Res200814216751676018980968
   PubMed Web of Science ®Google Scholar
• Santoyo-RamosPLikhatchevaMGarcia-ZepedaEACastaneda-PatlanMCRobles-FloresMHypoxia-inducible factors modulate the stemness and malignancy of colon cancer cells by playing opposite roles in canonical Wnt signalingPLoS One2014911e11258025396735
   PubMed Web of Science ®Google Scholar
• MasakiTGotoASugiyamaMPossible contribution of CD44 variant 6 and nuclear beta-catenin expression to the formation of budding tumor cells in patients with T1 colorectal carcinomaCancer200192102539254611745187
   PubMed Web of Science ®Google Scholar
• LauWMTengEChongHSCD44v8-10 is a cancer-specific marker for gastric cancer stem cellsCancer Res20147492630264124618343
   PubMed Web of Science ®Google Scholar
• WangDLuPZhangHOct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patientsOncotarget2014521108031081525301732
   PubMedGoogle Scholar
• CreightonCJLiXLandisMResidual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresProc Natl Acad Sci U S A200910633138201382519666588
   PubMed Web of Science ®Google Scholar
• KondoSWakisakaNMuramatsuMEpstein-Barr virus latent membrane protein 1 induces cancer stem/progenitor-like cells in nasopharyngeal epithelial cell linesJ Virol20118521112551126421849440
   PubMed Web of Science ®Google Scholar
• McFarlaneSMcFarlaneCMontgomeryNHillAWaughDJCD44-mediated activation of alpha5beta1-integrin, cortactin and paxillin signaling underpins adhesion of basal-like breast cancer cells to endothelium and Fibronectin-enriched matricesOncotarget2015634367623677326447611
   PubMedGoogle Scholar
• HanleyWDBurdickMMKonstantopoulosKSacksteinRCD44 on LS174T colon carcinoma cells possesses E-selectin ligand activityCancer Res200565135812581715994957
   PubMed Web of Science ®Google Scholar
• ShirureVSLiuTDelgadilloLFCD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditionsAm J Physiol Cell Physiol20153081C68C7825339657
   PubMed Web of Science ®Google Scholar
• McFarlaneSCoulterJATibbitsPCD44 increases the efficiency of distant metastasis of breast cancerOncotarget2015613114651147625888636
   PubMedGoogle Scholar
• KimYKumarSCD44-mediated adhesion to hyaluronic acid contributes to mechanosensing and invasive motilityMol Cancer Res201412101416142924962319
   PubMed Web of Science ®Google Scholar
• PerrotGLangloisBDevyJLRP-1 – CD44, a new cell surface complex regulating tumor cell adhesionMol Cell Biol201232163293330722711991
   PubMed Web of Science ®Google Scholar
• ZhangCXuYHaoQFOXP3 suppresses breast cancer metastasis through downregulation of CD44Int J Cancer201513761279129025683728
   PubMed Web of Science ®Google Scholar
• PaulisYWHuijbersEJvan der SchaftDWCD44 enhances tumor aggressiveness by promoting tumor cell plasticityOncotarget2015623196341964626189059
   PubMedGoogle Scholar
• FangXJXuWLGongJLChenCFangLLChenQYCD44 variant increases the invasive ability of human breast cancer cell line MCF-7 cellsZhonghua Zhong Liu Za Zhi2010321222820211062
   PubMedGoogle Scholar
• Herrera-GayolAJothySCD44 modulates Hs578T human breast cancer cell adhesion, migration, and invasivenessExp Mol Pathol19996619910810331969
   PubMed Web of Science ®Google Scholar
• NamKOhSLeeKMYooSAShinICD44 regulates cell proliferation, migration, and invasion via modulation of c-Src transcription in human breast cancer cellsCell Signal20152791882189425979842
   PubMed Web of Science ®Google Scholar
• MontgomeryNHillAMcFarlaneSCD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activityBreast Cancer Res2012143R8422621373
   PubMed Web of Science ®Google Scholar
• KlarmannGJHurtEMMathewsLAInvasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signatureClin Exp Metastasis200926543344619221883
   PubMed Web of Science ®Google Scholar
• GaoYFosterRYangXUp-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancerOncotarget20156119313932625823654
   PubMedGoogle Scholar
• Martin-VillarEFernandez-MunozBParsonsMPodoplanin associates with CD44 to promote directional cell migrationMol Biol Cell201021244387439920962267
   PubMed Web of Science ®Google Scholar
• MikamiSMizunoRKosakaTSayaHOyaMOkadaYExpression of TNF-alpha and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomasInt J Cancer201513671504151425123505
   PubMed Web of Science ®Google Scholar
• NicoliniAFerrariPFiniMStem cells: their role in breast cancer development and resistance to treatmentCurr Pharm Biotechnol201112219620521044007
   PubMed Web of Science ®Google Scholar
• WeiXXuMWeiYThe addition of rituximab to CHOP therapy alters the prognostic significance of CD44 expressionJ Hematol Oncol201473424739401
   PubMed Web of Science ®Google Scholar
• NiJCozziPJHaoJLCD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistanceProstate201474660261724615685
   PubMed Web of Science ®Google Scholar
• JinLHopeKJZhaiQSmadja-JoffeFDickJETargeting of CD44 eradicates human acute myeloid leukemia stem cellsNat Med200612101167117416998484
   PubMed Web of Science ®Google Scholar
• DanTHewittSMOhriNCD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-upBreast Cancer Res Treat20141431111824276281
   PubMed Web of Science ®Google Scholar
• WuXJLiXDZhangHClinical significance of CD44s, CD44v3 and CD44v6 in breast cancerJ Int Med Res201543217317925571897
   PubMed Web of Science ®Google Scholar
• GoSIKoGHLeeWSCD44 variant 9 serves as a poor prognostic marker in early gastric cancer, but not in advanced gastric cancerCancer Res Treat Epub2015317
   Web of Science ®Google Scholar
• AhmedMAAleskandaranyMARakhaEAA CD44(−)/CD24(+) phenotype is a poor prognostic marker in early invasive breast cancerBreast Cancer Res Treat2012133397999522119938
   PubMed Web of Science ®Google Scholar
• BasakranNSCD44 as a potential diagnostic tumor markerSaudi Med J201536327327925737167
   PubMed Web of Science ®Google Scholar
• JiangLDengJZhuXCD44 rs13347 C.T polymorphism predicts breast cancer risk and prognosis in Chinese populationsBreast Cancer Res2012144R10522788972
   PubMed Web of Science ®Google Scholar
• LuXXuKLuHCD44(+)/CD24(−) cells are transit progenitors and do not determine the molecular subtypes and clinical parameters in breast carcinomasUltrastruct Pathol2011352727821299347
   PubMed Web of Science ®Google Scholar